These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17645054)

  • 1. [Daily low dose aspirin for patients in high risk].
    Born GV
    Rev Med Suisse; 2007 May; 3(113):1400. PubMed ID: 17645054
    [No Abstract]   [Full Text] [Related]  

  • 2. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
    Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
    J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the time of taking aspirin influence the frequency of cardiovascular events?
    Kriszbacher I; Ajtay Z; Koppán M; Bódis J
    Am J Cardiol; 2005 Aug; 96(4):608-10. PubMed ID: 16098324
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical memo. Low-dose aspirin gets the nod.
    Harv Mens Health Watch; 2001 Mar; 5(8):7. PubMed ID: 11276157
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin resistance: is it real? Is it clinically significant?
    Dalen JE
    Am J Med; 2007 Jan; 120(1):1-4. PubMed ID: 17208069
    [No Abstract]   [Full Text] [Related]  

  • 6. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.
    Berger JS; Brown DL; Becker RC
    Am J Med; 2008 Jan; 121(1):43-9. PubMed ID: 18187072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin in polycythemia vera.
    Denes AE
    N Engl J Med; 2004 Apr; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088323
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of aspirin in diabetic patients].
    Türkoğlu S; Abaci A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():5-8. PubMed ID: 18160360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin and gastrointestinal toxicity.
    Törüner M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin "resistance" and its impact on cardiovascular morbidity and mortality: it is real, clinically relevant and should be measured.
    Brister SJ; Buchanan MR
    Heart; 2009 Aug; 95(15):1223-4. PubMed ID: 19398437
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin resistance testing not ready for "prime time".
    Hjemdahl P
    Heart; 2009 Aug; 95(15):1220-2. PubMed ID: 19398435
    [No Abstract]   [Full Text] [Related]  

  • 14. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].
    Mooe T
    Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiplatelet therapy.
    Wood SF
    Br J Gen Pract; 1996 Aug; 46(409):494-5. PubMed ID: 8949338
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethical considerations in relation to aspirin prophylaxis.
    Morgan G
    Qual Prim Care; 2008; 16(6):433-40. PubMed ID: 19094419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When it comes to aspirin, men and women are not equal: aspirin acts differently in women.
    Sofer D
    Am J Nurs; 2005 Jun; 105(6):20. PubMed ID: 15930857
    [No Abstract]   [Full Text] [Related]  

  • 19. What is the best dose of aspirin in association with P2Y12 antagonists?
    Cattaneo M
    Heart; 2011 Feb; 97(3):263-4; author reply 264. PubMed ID: 21189314
    [No Abstract]   [Full Text] [Related]  

  • 20. Weighing the benefits and risks of aspirin for primary prevention of vascular disease.
    Garg MK
    J Assoc Physicians India; 2010 May; 58():331. PubMed ID: 21117359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.